Ishita Drugs and Industries Ltd

ISHITADR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11 cr, stock is ranked 3,173
High RiskStock is 4.22x as volatile as Nifty
40.250.75 (+1.90%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11 cr, stock is ranked 3,173
High RiskStock is 4.22x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
14.23
PB RatioPB Ratio
1.52
Dividend YieldDiv. Yield
Sector PESector PE
38.42
Sector PBSector PB
5.12
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ishita Drugs And Industries is engaged in the manufacturing of various active pharma ingredients, drug intermediates, excipients and fine chemicals.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020217.029.2514.9914.260.250.340.540.83
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Result 
Announced OnNov 26, 2021

Ishita Drugs & Industries Ltd - 524400 - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. | Download

Ishita Drugs & Industries Ltd - 524400 - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. | Download

Result 
Announced OnNov 2, 2021

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Outcome for Outcome Of Board Meeting Held On 2Nd November, 2021 Pursuant To Regulation 30 And 33 Of SEBI (LODR) Regulation, 2015. | Download

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Outcome for Outcome Of Board Meeting Held On 2Nd November, 2021 Pursuant To Regulation 30 And 33 Of SEBI (LODR) Regulation, 2015. | Download

Board Meeting 
Announced OnOct 27, 2021

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 And Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter And Half - Year Ended On 30Th September, 2021 | Download

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 And Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter And Half - Year Ended On 30Th September, 2021 | Download

See all events